Enhanced Cell Killing by Overexpression of Dominant-negative Phosphatidylinositol 3-Kinase Subunit, Δp85, Following Genotoxic Stresses
- 1 December 2000
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 91 (12), 1314-1318
- https://doi.org/10.1111/j.1349-7006.2000.tb00919.x
Abstract
Phosphatidylinositol 3‐kinase (PI3‐K) is a heterodimer of a regulatory subunit, p85, and a catalytic subunit, p110. A number of previous reports showed that PI3‐K functions in diverse cellular phenomena such as cell proliferation, glucose catabolism, cell adhesion, and vesicle transport. It is also well known that a survival signal from the receptor tyrosine kinases utilizes Akt via PI3‐K to protect cells from apoptosis. To examine the role of PI3‐K in cellular sensitivity to genotoxic stresses such as cisplatin and ultraviolet (UV), we introduced deletion type p85 (Δp85) into two human glioblastoma cell lines (T98G and A172) and one melanoma cell line (G361). The Δp85 works in a dominant‐negative fashion on PI3‐K activity by disrupting its p85/p110 interaction. In all three transfected cell lines, the overexpression of Δp85 rendered the cells markedly more sensitive to these DNA‐damaging stresses than the cells transfected with the vector alone. Apoptosis was vigorously induced in cells overexpressing Δp85 following the treatment. The present results imply that PI3‐K plays a critical role in determining cellular sensitivity to genotoxic stresses in human cancer cells, and that disruption of the p85/p110 interaction of PI3‐K may be a potential molecular target for developing a novel strategy for cancer treatment.Keywords
This publication has 19 references indexed in Scilit:
- Akt/Protein Kinase B Up-regulates Bcl-2 Expression through cAMP-response Element-binding ProteinJournal of Biological Chemistry, 2000
- p21Waf1/cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell lineInternational Journal of Cancer, 1999
- The chemoresistance of human malignant melanomaMelanoma Research, 1999
- Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathwayThe EMBO Journal, 1997
- The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.Genes & Development, 1997
- Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and AktMolecular and Cellular Biology, 1997
- PI3K: Downstream AKTion Blocks ApoptosisCell, 1997
- Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKBNature, 1997
- Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not C-RAF-1 proteinInternational Journal of Cancer, 1996
- Phosphoinositide kinasesCurrent Opinion in Cell Biology, 1996